Milvexian for prevention and treatment of thromboembolic disorders
NZ837042APending Publication Date: 2026-10-30BRISTOL MYERS SQUIBB CO +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- NZ837042
- Authority / Receiving Office
- NZ · NZ
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-12
- Filing Date
- 2022-09-16
- Publication Date
- 2026-10-30
Smart Images
Figure 1_ABST
Abstract
The factor Xia inhibitor milvexian has therapeutic properties useful in the treatment and / or prevention of thrombotic and thromboembolic disorders.
Need to check novelty before this filing date? Find Prior Art